Single arm and single center clinical research on traditional Chinese medicine in combination with apatinib for the treatment of stage Ⅳ malignant tumor
Background and purpose: Apatinib is only approved for third-line treatment of advanced gastric cancer in China. However in recent years, antiangiogenic drugs have shown remarkable efficacy in a variety of advanced solid tumors. A large number of clinical studies have confirmed that the comprehensive...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Editorial Office of China Oncology
2018-12-01
|
| Σειρά: | Zhongguo aizheng zazhi |
| Θέματα: | |
| Διαθέσιμο Online: | http://www.china-oncology.com/thesisDetails#10.19401/j.cnki.1007-3639.2018.11.006 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|